{
    "Symbol": "NTRA",
    "AssetType": "Common Stock",
    "Name": "Natera Inc",
    "Description": "Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.",
    "CIK": "1604821",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "SERVICES-MEDICAL LABORATORIES",
    "Address": "201 INDUSTRIAL ROAD, SUITE 410, SAN CARLOS, CA, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "12648709000",
    "EBITDA": "-358575008",
    "PERatio": "None",
    "PEGRatio": "0",
    "BookValue": "6.5",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-3.11",
    "RevenuePerShareTTM": "10.31",
    "ProfitMargin": "-0.302",
    "OperatingMarginTTM": "-0.202",
    "ReturnOnAssetsTTM": "-0.171",
    "ReturnOnEquityTTM": "-0.506",
    "RevenueTTM": "1208556000",
    "GrossProfitTTM": "363966000",
    "DilutedEPSTTM": "-3.11",
    "QuarterlyEarningsGrowthYOY": "0",
    "QuarterlyRevenueGrowthYOY": "0.521",
    "AnalystTargetPrice": "125.39",
    "AnalystRatingStrongBuy": "8",
    "AnalystRatingBuy": "9",
    "AnalystRatingHold": "0",
    "AnalystRatingSell": "1",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "-",
    "PriceToSalesRatioTTM": "10.54",
    "PriceToBookRatio": "14.9",
    "EVToRevenue": "10.13",
    "EVToEBITDA": "-27.58",
    "Beta": "1.48",
    "52WeekHigh": "117.23",
    "52WeekLow": "36.9",
    "50DayMovingAverage": "108.49",
    "200DayMovingAverage": "80.86",
    "SharesOutstanding": "122803000",
    "DividendDate": "None",
    "ExDividendDate": "None"
}